Last Updated: Thursday, July 23, 2015, 20:34
Drug firm Wockhardt, which has been under the USFDA scanner, Thursday said that United States health regulator has completed inspection of its Nalagarh facility in Himachal Pradesh.
Last Updated: Thursday, July 23, 2015, 16:49
Drug major Lupin Thursday said it is acquiring US-based Gavis for USD 880 million (over Rs 5,610 crore) to consolidate presence in the world's largest pharmaceuticals market.
Last Updated: Thursday, July 23, 2015, 16:08
The company had posted a net profit after taxes and minority interest of Rs 624.74 crore for the corresponding period of the previous fiscal, Lupin said in a filing to BSE.
Last Updated: Tuesday, July 21, 2015, 22:13
Drug firm Sanofi India Tuesday reported a 11.65 percent rise in its standalone net profit at Rs 64.2 crore during second quarter ended June 30, 2015.
Last Updated: Tuesday, July 21, 2015, 11:19
Drug major Cipla on Tuesday said its board has approved a potential investment by FIL Capital Investments (Mauritius) II Ltd in its consumer healthcare business.
Last Updated: Saturday, July 18, 2015, 14:00
Drug firm Torrent Pharmaceuticals on Saturday said that it has completed acquisition of Encore Group firm Zyg Pharma Pvt Ltd.
Last Updated: Thursday, July 16, 2015, 19:22
The Supreme Court has asked the central government to reexamine its pricing policy for essential medicines after a group of non-governmental organisations challenged the provisions, a lawyer involved in the case said.
Last Updated: Thursday, July 16, 2015, 19:05
As per the information available on the US Food and Drug Administration's (USFDA) website, Mumbai-based Wockhardt is recalling the drugs for current good manufacturing practice (CGMP) deviations.
Last Updated: Thursday, July 16, 2015, 12:28
The Supreme Court has asked the federal government to re-examine its pricing policy for essential medicines, the Times of India reported on Thursday.
Last Updated: Thursday, July 16, 2015, 11:34
India has extended price caps to an additional 39 drugs ranging from commonly used diabetes treatments to antibiotics, in the government`s latest effort to improve the affordability of medicines.
Last Updated: Wednesday, July 15, 2015, 14:44
Drug firm Pfizer is planning to close its Navi Mumbai plant from September 16, 2015.
Last Updated: Tuesday, July 7, 2015, 20:42
Brazilian drug regulator ANVISA has suspended import of active ingredients produced by pharma major Lupin used to make antibiotics, citing "unsatisfactory inputs" and deviation from good manufacturing practices (GMP).
more videos >>
